Skip to content

Improving Screening and Therapy for Hispanic/Latinx at Risk for CKD

Improving Screening and Therapy Provision Among Hispanics/Latinx at Risk for Chronic Kidney Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05734989
Enrollment
59
Registered
2023-02-21
Start date
2023-05-18
Completion date
2025-04-04
Last updated
2025-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes, Chronic Kidney Diseases

Brief summary

In this study, the investigators will utilize community organizations to screen Hispanics/Latino(a)s for kidney disease, diabetes, and other risk factors, and refer them for care with a PCP. Additionally, the investigators will implement an intervention in local health clinics to assist PCPs with screening and treating patients with diabetes. Completion of the project will hopefully slow progression of kidney disease among Hispanic/Latino(a) patients in Durham, and the information gained will allow the investigators to eventually perform the intervention on a larger scale.

Detailed description

The goals of this study are to (1) Increase rates of screening and monitoring of CKD and CKD risk factors for Hispanic/Latinx community members in Durham by utilizing existing community resources and screening events and (2) Pilot test a PCP-facing intervention to promote guideline concordant testing and evidence-based therapy provision for Hispanics/Latinx with T2D at community health centers, utilizing clinical champions and pharmacists. The investigators anticipate the study will identify patients with CKD or CKD risk factors and establish feasibility of the pilot intervention, which the investigators plan to ultimately apply on a large scale to reduce inequities and improve clinical outcomes among Hispanics/Latinx.

Interventions

DIAGNOSTIC_TESTBP

Blood pressure measurements and HbA1c tests will be conducted to identify participants with or at risk for high blood pressure and/or Type 2 Diabetes. Those identified will be referred to PCP for follow up/treatment.

DIAGNOSTIC_TESTHbA1c

HbA1c will screen to identify patients with Type 2 diabetes

BEHAVIORALPCP Guidelines for Screening and Monitoring Hispanic/Latinx patients for CKD

Guidelines will be developed and provided to PCPs to use with their Hispanic/Latinx patients with or at risk for CKD.

Sponsors

National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Aim 1: Inclusion Criteria: * Age 18 or older at time of screening * Self-identifying as Hispanic/Latinx ethnicity.

Exclusion criteria

* Unable to be reached by telephone

Design outcomes

Primary

MeasureTime frameDescription
Number of patients referred to PCPs (Primary Care Providers) for CKD screening3 months from referralIncrease rates of screening and monitoring of Chronic Kidney Disease (CKD) and CKD risk factors for Hispanic/Latinx community members in Durham by utilizing existing community resources and screening events

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026